Comments
GSK insists it best owner for Human Genome
25.04.2012. | LONDON (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday its $2.6 billion bid for long-time partner Human Genome Sciences was "full and fair" and it was the only obvious owner for the U.S. biotechnology firm....
